We are thrilled to annouce that the first data results from the 3TR-ABC study have been presented at the European Respiratory Society Congress 2022 in Barcelona. C. Bernhoff and colleagues have found that participants with severe asthma show signs of cognitive impairment – a found that is well in line with patient reports of decreased concentration and memory. Sofar the results are based on a limited number of patients but as the 3TR-ABC study progress more data will be available. Also, it will be exciting to see if patients’ cognitive functions improve after receiving biological treatment!!!
FIRST DATA FROM THE 3TR-ABC STUDY PRESENTED AT THE ERS CONGRESS 2022
